Copy Link Print Information

JSH-23

159 Cited Publications
Avis client

Based on 159 publication(s) in Google Scholar

JSH-23 is an NF-κB inhibitor which inhibits NF-κB transcriptional activity with an IC50 of 7.1 μM in lipopolysaccharide (LPS)-stimulated macrophages RAW 264.7. JSH-23 inhibits nuclear translocation of NF-κB p65 without affecting IκBα degradation.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 98.02%
  • CAS No.: 749886-87-1
  • Formule: C16H20N2
  • Masse moléculaire:240.34
  • Stockage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 2 years , -20°C, 1 year
  • JSH-23 Chemical Structure
    JSH-23 Chemical Structure
  • Experimental Validation Results for JSH-23
  • Experimental Validation Results for JSH-23
  • Experimental Validation Results for JSH-23
  • Experimental Validation Results for JSH-23
  • Experimental Validation Results for JSH-23
  • Experimental Validation Results for JSH-23
  • Experimental Validation Results for JSH-23
CAS No.: 749886-87-1
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of JSH-23:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Solvant et solubilité
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) JSH-23

More
Customer Validation & Images
WBRT-PCR
  • WB
  • RT-PCR
  • WB
  • WB
  • WB
  • WB
  • WB

Voir tous les produits spécifiques à Isoform NF-κB

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • JSH-23 Chemical Structure
    JSH-23 Chemical Structure
    1/16
  • 1/16

    JSH-23 purchased from MedChemExpress. Usage Cited in: Cell Rep. 2023 Apr 14;42(4):112403. [Abstract]

    Customer Validation
     JSH-23 (10 μM; 6 days) significantly inhibits nuclear translocation of NF-kB p65 in SSC cells.

  • 1/16

    JSH-23 purchased from MedChemExpress. Usage Cited in: Front Bioeng Biotechnol. 2020 May 8:8:392. [Abstract]

    Customer Validation
     Acta2 expression after Signaling inhibitors by q-PCR. For inhibitor treatment, 24 h after seeding, the medium is removed and replaced with the NF-κB inhibitor JSH-23 (50 μM) to block the NF-κB signaling pathways.

  • 1/16

    JSH-23 purchased from MedChemExpress. Usage Cited in: Cancer Lett. 2018 Aug 1:428:77-89. [Abstract]

    Customer Validation
     Western blots show that the NF-κB inhibitors BAY11-7082, Parthenolide, and JSH-23 cause dramatic time- and dose-dependent reductions in MGMT protein expression in LN18 and T98G glioma cells.

  • 1/16

    JSH-23 purchased from MedChemExpress. Usage Cited in: J Mol Cell Biol. 2019 Jun 1;11(6):496-508. [Abstract]

    Customer Validation
     Cytoplasmic LPS-induced GSDMB and GSDMD expression are both significantly attenuated by either JSH-23 or QNZ.

  • 1/16

    JSH-23 purchased from MedChemExpress. Usage Cited in: Front Pharmacol. 2018 Jun 21:9:660. [Abstract]

    Customer Validation
     By Western blotting, the α-SMA and palladin proteins are determined in cells that are pretreated with NF-κB (JSH-23), Wnt/β-catenin (XAV939), EGFR (erlotinib), p38 MAPK (TAK-715), and Smad3 (SIS3) inhibitors and are followed by TWEAK stimulation.

  • 1/16

    JSH-23 purchased from MedChemExpress. Usage Cited in: Int J Clin Exp Pathol. 2017;10(6):6544-6551.

    Customer Validation
     JSH-23 is added into MDA-MB-231 cells with the dose of 0 μmol, 1 μmol, 5 μmol when the cell planking density reaches about 60%. Then samples incubated for 24 h are collected when the cell density reaches about 80% and confirmed by western blot.

  • 1/16

    JSH-23 purchased from MedChemExpress. Usage Cited in: PLoS One. 2016 Nov 16;11(11):e0166740. [Abstract]

    Customer Validation
     HG-induced apoptosis in neonatal rat cardiomyocytes is mediated by activation of the NF-κB pathway. (A-B). Neonatal rat cardiomyocytes are pretreated with 10–20 μM JSH-23 and exposed to HG for 36 h. Levels of caspase-3 and cleaved caspase-3 and Bax/Bcl-2 ratios are determined by western blotting.

  • JSH-23